Role of endothelium-derived nitric oxide in the regulation of blood pressure.

Abstract

The role of endothelium-derived nitric oxide in the regulation of blood pressure in the anesthetized rabbit was studied with N.omega.-monomethyl-L-arginine (L-NMMA), a specific inhibitor of its formation from L-arginine. L-NMMA (3-100 mg.cntdot.kg-1), but not its D-enantiomer, induced a dose-dependent long-lasting (15-90 min) increase in mean systemic arterial blood pressure. L-NMMA (100 mg.cntdot.kg-1) also inhibited significantly the hypotensive action of acetylcholine, without affecting that of glyceryl trinitrate. Both these actions of L-NMMA were reversed by L-arginine (300 mg.cntdot.kg-1), but not by D-arginine (300 mg.cntdot.kg-1), indomethacin (1 mg.cntdot.kg-1), prazosin (0.3 mg.cntdot.kg-1), or by vagotomy. The effects of L-NMMA in vivo were associated with a significant inhibition of the release of nitric oxide from perfused aortic segments ex vivo. This inhibition was reversed by infusing L-arginine through the aortic segments. These results indicate that nitric oxide formation from L-arginine by the vascular endothelium plays a role in the regulation of blood pressure and in the hypotensive actions of acetylcholine.